Cargando…
S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428396/ http://dx.doi.org/10.1097/01.HS9.0000967780.46838.75 |
| _version_ | 1785090459056472064 |
|---|---|
| author | Guolo, Fabio Minetto, Paola Pesce, Silvia Ballerini, Filippo Cea, Michele Greppi, Marco Bozzo, Matteo Miglino, Maurizio Tedone, Elisabetta Bo, Alessandra Serio, Alberto Luchetti, Silvia Candiani, Simona Mora, Marco Agostini, Vanessa Nozza, Paolo Del Zotto, Genny Marcenaro, Emanuela Lemoli, Roberto Massimo |
| author_facet | Guolo, Fabio Minetto, Paola Pesce, Silvia Ballerini, Filippo Cea, Michele Greppi, Marco Bozzo, Matteo Miglino, Maurizio Tedone, Elisabetta Bo, Alessandra Serio, Alberto Luchetti, Silvia Candiani, Simona Mora, Marco Agostini, Vanessa Nozza, Paolo Del Zotto, Genny Marcenaro, Emanuela Lemoli, Roberto Massimo |
| author_sort | Guolo, Fabio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428396 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283962023-08-17 S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION Guolo, Fabio Minetto, Paola Pesce, Silvia Ballerini, Filippo Cea, Michele Greppi, Marco Bozzo, Matteo Miglino, Maurizio Tedone, Elisabetta Bo, Alessandra Serio, Alberto Luchetti, Silvia Candiani, Simona Mora, Marco Agostini, Vanessa Nozza, Paolo Del Zotto, Genny Marcenaro, Emanuela Lemoli, Roberto Massimo Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428396/ http://dx.doi.org/10.1097/01.HS9.0000967780.46838.75 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Guolo, Fabio Minetto, Paola Pesce, Silvia Ballerini, Filippo Cea, Michele Greppi, Marco Bozzo, Matteo Miglino, Maurizio Tedone, Elisabetta Bo, Alessandra Serio, Alberto Luchetti, Silvia Candiani, Simona Mora, Marco Agostini, Vanessa Nozza, Paolo Del Zotto, Genny Marcenaro, Emanuela Lemoli, Roberto Massimo S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION |
| title | S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION |
| title_full | S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION |
| title_fullStr | S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION |
| title_full_unstemmed | S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION |
| title_short | S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION |
| title_sort | s217: post-transplant nivolumab plus unselected autologous lymphocytes in refractory hodgkin lymphoma results in very high remission rate and excellent survival and it is associated with nk cell expansion |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428396/ http://dx.doi.org/10.1097/01.HS9.0000967780.46838.75 |
| work_keys_str_mv | AT guolofabio s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT minettopaola s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT pescesilvia s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT ballerinifilippo s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT ceamichele s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT greppimarco s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT bozzomatteo s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT miglinomaurizio s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT tedoneelisabetta s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT boalessandra s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT serioalberto s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT luchettisilvia s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT candianisimona s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT moramarco s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT agostinivanessa s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT nozzapaolo s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT delzottogenny s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT marcenaroemanuela s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion AT lemolirobertomassimo s217posttransplantnivolumabplusunselectedautologouslymphocytesinrefractoryhodgkinlymphomaresultsinveryhighremissionrateandexcellentsurvivalanditisassociatedwithnkcellexpansion |